Further evidence that the control of lncRNA NEAT1 expression in NAFLD subjects is connected to liver function and lipid metabolism comes from the robust correlation between the lncRNA NEAT1 expression in the peripheral blood of NAFLD patients and the ALT, GGT, TC, and TG levels [129]. The gene discussed is NEAT1; the disease is metabolic dysfunction-associated steatotic liver disease.